Copyright © Inderes 2011 - present. All rights reserved.

ChemoMetec

297.00 DKK

+5.84 %

Less than 1K followers

CHEMM

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

+5.84 %
-22.90 %
-56.80 %
-56.55 %
-52.25 %
-42.83 %
-21.68 %
-46.39 %
+1,250.00 %

ChemoMetec specializes in the design, development, and production of patented instruments for cell counting and cell analysis. The company cooperates and statutes agreements with actors such as research institutes, universities, food companies, hospitals, and specialist clinics. Customers are found in a global market. The company was founded in 1997 and is headquartered in Alleröd, Denmark.

Read more
Market cap
5.17B DKK
Turnover
109.74M DKK
Revenue
495.57M
EBIT %
47.73 %
P/E
27.73
Dividend yield-%
2.36 %
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
10.9
2026

Annual report '26

8.10
2026

General meeting '26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
HCA Morgenbørs 23/01 - Udsigt til flad stemning i Europa med fokus på Novo Nordisk og Bavarian
Video by
Michael Friis, Rasmus Køjborg

HCA Morgenbørs 23/01 - Udsigt til flad stemning i Europa med fokus på Novo Nordisk og Bavarian

I dagens Morgenbørs ser vi ind i flade EU futures efter stor optur i går. Herhjemme fokus på Novo på receptal og Bavarian.

PandoraMT Højgaard HoldingNovo NordiskBavarian NordicA.P. Møller - MærskGN Store NordNordea BankFøroya BankiSkjern BankDanske Andelskassers BankAquaporinChemoMetecGomSpace GroupRovsingDanish Aerospace Company
HCA Morgenbørs 10/11 - Positive futures på mulig genåbning i USA og fokus på Novo Nordisk
Video by
Michael Friis, Rasmus Køjborg

HCA Morgenbørs 10/11 - Positive futures på mulig genåbning i USA og fokus på Novo Nordisk

I dagens Morgenbørs ser vi ind i et stort hop op i de amerikanske futures på en mulig amerikansk genåbning. Herhjemme er der blandt andet fokus på Novo Nordisk og Genmab.

Novo NordiskChemoMetecGenmabNTG Nordic Transport GroupH+H InternationalWirtekFLSmidth & Co.LundbeckSchouw & CoMatasRoyal UnibrewALK-AbellóZealand PharmaBavarian Nordic
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.